Long-Term Results of Physician-Modified Endografts for the Treatment of Elective, Symptomatic, and Ruptured Juxtarenal Abdominal Aortic Aneurysms

被引:3
|
作者
Starnes, Benjamin W. [1 ]
Zettervall, Sara [1 ]
Larimore, Allison [1 ]
Singh, Niten [1 ]
机构
[1] Univ Washington, Dept Surg, Div Vasc Surg, Seattle, WA 98195 USA
关键词
physician modified endografts; juxtarenal abdominal aortic aneurysm; fenestrated; MODIFIED ENDOVASCULAR GRAFTS; EXEMPTION CLINICAL-TRIAL; REPAIR; DEVICE; OUTCOMES;
D O I
10.1097/SLA.0000000000006422
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective:The objective of this study was to report long-term results of an ongoing physician-sponsored, investigational device exemption (IDE) pivotal clinical trial using physician-modified endovascular grafts (PMEGs) for the treatment of patients with juxtarenal aortic aneurysms. Methods:Data from a nonrandomized, prospective, consecutively enrolling IDE clinical trial were used. Data collection began on April 1, 2011, and data lock occurred on January 2, 2024, with outcomes analysis through December 31, 2023. Primary safety and effectiveness end points were used to measure treatment success. The safety end point was defined as the proportion of subjects who experienced a major adverse event within 30 days of the procedure. The effectiveness end point was the proportion of subjects who achieved treatment success. Treatment success required the following at 12 months: technical success, defined as successful delivery and deployment of a PMEG with preservation of intended branch vessels; and freedom from: type I and III endoleak, stent graft migration >10 mm, aortic aneurysm sack enlargement >5 mm, and aortic aneurysm rupture or open conversion. Results:Over the 12-year study period, 228 patients were enrolled; 205 began the implant procedure, and 203 received PMEG. Thirteen patients withdrew prior to PMEG. Two withdrew (<1.0%) after failure to deploy due to tortuous iliac anatomy and are tracked as intent to treat, and a total of 24 withdrew after receiving the PMEG implant. Forty-four patients died during the study period. A total of 14 were deemed lost to follow-up. Fifty-nine completed the 5-year follow-up period, and 62 remain active in follow-up visits.Aneurysm anatomy, operative details, and lengths of stay were recorded and included: aneurysm diameter (mean, 67.5 mm; range, 49-124 mm), proximal seal zone length (mean, 41.6 mm; range, 18.9-92.9 mm), graft modification time (mean, 48.7 min), procedure time (mean, 137.7 min), fluoroscopy time (mean, 33.8 min), contrast material use (mean, 93.0 mL), estimated blood loss (mean, 118.8 mL), length of hospital stay (mean, 3.7 d), and intensive care unit length of stay (mean, 1.6 d).A total of 575 fenestrations were created for 387 renal arteries, 181 superior mesenteric arteries (SMAs), and 7 celiac arteries. Renal arteries were in 96% of patients and included 410 renal artery stents in 203 patients. The SMA was stented as needed and included one patient with an SMA stent placed before the procedure, 19 during the procedure, and 2 patients who underwent stent placement after the procedure. There were no open conversions or device migrations and 1 partial explant due to late distal graft occlusion. Three ruptures (1.4%) were recorded on days 830, 1346, and 1460. There was 1 presumed graft infection at 750 days (<0.5%) treated with? Thirty-day all-cause mortality was 2.9% (6/204). One type Ia, 1 type Ib, and 7 type III endoleaks were identified during follow-up and treated with successful reintervention at the 1-year period. The overall rate of major adverse events at 30 days was 15% (29/194). Technical success was 93.7%, and overall treatment success was 82.6%. Conclusions:PMEG can be performed with low rates of long-term morbidity and mortality, confirming our early and midterm reports that endovascular repair with PMEG is safe, durable, and effective for managing patients with juxtarenal aortic aneurysms. While historically considered experimental, these results suggest that PMEG is a safe and durable option and should be considered for patients where off-the-shelf devices are not available.
引用
收藏
页码:633 / 639
页数:7
相关论文
共 50 条
  • [41] Determinants of the postoperative and long-term survival of patients with ruptured abdominal aortic aneurysms
    Sasaki, S
    Yasuda, K
    Yamauchi, H
    Shiiya, N
    Sakuma, M
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1998, 28 (01): : 30 - 35
  • [42] Determinants of the postoperative and long-term survival of patients with ruptured abdominal aortic aneurysms
    Shigeyuki Sasaki
    Keishu Yasuda
    Hidetoshi Yamauchi
    Norihiko Shiiya
    Makoto Sakuma
    Surgery Today, 1998, 28 : 30 - 35
  • [43] LONG-TERM RESULTS OF 102 ABDOMINAL AORTIC-ANEURYSMS
    OHARA, M
    ZEMPO, N
    NAKAMURA, T
    FUJIOKA, K
    TAKENAKA, H
    ESATO, K
    VASCULAR SURGERY, 1991, 25 (02): : 105 - 111
  • [44] Physician-Modified Endografts for Non-deferrable Complex Abdominal Aortic Aneurysm Repair Using the Endurant Platform: Templates and Initial Results
    Marcos, Francisco Alvarez
    Valdivia, Andres Reyes
    Bravo, Mariano De Blas
    Perez, Manuel Alonso
    JOURNAL OF ENDOVASCULAR THERAPY, 2025,
  • [45] Long-term durability of a physician-modified endovascular graft
    Hurd, Jason R.
    Tatum, Billi
    Grillo, Jenna
    Arthurs, Zachary
    Singh, Niten
    Fong, Hanson
    Sarikaya, Mehmet
    Allen-Kline, Brenda
    Starnes, Benjamin W.
    JOURNAL OF VASCULAR SURGERY, 2020, 71 (02) : 628 - 634
  • [46] Systematic Review and Meta-analysis of Physician Modified Endografts for Treatment of Thoraco-Abdominal and Complex Abdominal Aortic Aneurysms
    Gouveia e Melo, Ryan
    Prendes, Carlota Fernandez
    Caldeira, Daniel
    Stana, Jan
    Rantner, Barbara
    Wanhainen, Anders
    Oderich, Gustavo S.
    Tsilimparis, Nikolaos
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2022, 64 (2-3) : 188 - 199
  • [47] Physician-Modified Endovascular Grafts for Treatment of Juxtarenal Aortic Aneurysms: Midterm Results From an Investigator-Initiated Investigational Device Exemption (IDE) Clinical Trial
    Heneghan, Rachel E.
    Tatum, Billi
    Starnes, Benjamin W.
    JOURNAL OF VASCULAR SURGERY, 2015, 62 (02) : 526 - 526
  • [48] Five Year Results of Off the Shelf Fenestrated Endografts for Elective and Emergency Repair of Juxtarenal Abdominal Aortic Aneurysm
    Sveinsson, Magnus
    Sonesson, Bjorn
    Dias, Nuno
    Bjorses, Katarina
    Kristmundsson, Thorarinn
    Resch, Timothy
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2021, 61 (04) : 550 - 558
  • [49] Inflammatory abdominal aortic aneurysms and atherosclerotic abdominal aortic aneurysms - Comparisons of clinical features and long-term results
    Sasaki, S
    Yasuda, K
    Takigami, K
    Yamauchi, H
    Shiiya, N
    Sakuma, M
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1997, 61 (03): : 231 - 235
  • [50] SYMPTOMATIC ABDOMINAL AORTIC-ANEURYSMS IN LONG-TERM SURVIVORS OF CARDIAC TRANSPLANTATION
    REICHMAN, W
    DYKE, C
    LEE, HM
    HANRAHAN, J
    SZENTPETERY, S
    SOBEL, M
    JOURNAL OF VASCULAR SURGERY, 1990, 11 (03) : 476 - 479